Review of Recombinant Antibody Production Systems for Research and Therapy

A review article discusses the landscape of recombinant antibody production systems over the past three decades. Authored by Esther Veronika Wenzel and published on figshare in May 2026, the 352.7 KB PDF likely contains a scholarly analysis of various expression hosts and their applications.

Use Cases

• Compare production yields and product quality of mammalian cell lines like CHO cells based on the review's discussion.
• Evaluate alternative expression systems for non-glycosylated antibody fragments based on the description of bacterial production.
• Survey regulatory-approved therapeutic antibodies based on the mention of EU and US approvals.
• Identify suitable hosts for diagnostic and research antibody reagents based on the listed range of systems.

Strengths

• Focuses on a critical and fast-growing field in biotechnology, as stated in the description.
• Covers a broad range of production systems including bacteria, yeasts, fungi, insect cells, and plants, as listed.
• Explicitly mentions regulatory approvals and clinical trials for some molecules.

Limitations

• Description metadata is limited; actual data quality requires manual inspection after download.
• Column-level documentation is absent; field semantics must be inferred after download.
• The 352.7 KB file size suggests a limited scope, likely a review article rather than a primary dataset.

Provenance

Source

figshare

Collection Method

Likely a literature review authored by a single researcher.

Freshness

Last updated 2026-05-20 08:05:02; freshness should be verified.